ORs for the outcome PTS
| Predictor . | Univariable analysis OR (95% CI) . | P . |
|---|---|---|
| Group | ||
| Non-LR vs LRnon-neonates | 2.17 (1.12-4.20) | .01 |
| LRneonates vs LRnon-neonates | 0.67 (0.34-1.33) | |
| Treatment | ||
| None/prophylaxis vs thrombolysis | 0.20 (0.04-0.90) | .02 |
| Anticoagulants vs thrombolysis | 0.26 (0.10-0.66) | |
| Delay to start therapy, d | 1.03 (0.99-1.06) | .16 |
| Length of therapy, mo | 1.02 (0.98-1.05) | .37 |
| Age at the time of LE-DVT, y | 1.08 (1.03-1.12) | <.001 |
| Sex (male vs female) | 1.38 (0.80-2.38) | .24 |
| Number of affected venous segments | 1.36 (1.12-1.66) | .002 |
| DVT level (femoro-popliteal vs ilio-femoral) | 0.48 (0.11-2.15) | .34 |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 2.20 (0.95-5.09) | .07 |
| Recurrence (yes vs no) | 0.99 (0.21-4.78) | .98 |
| Thrombophilia | ||
| None vs major | 0.71 (0.29-1.72) | .78 |
| Minor vs major | 0.79 (0.25-2.43) | |
| DVT resolution (none/partial vs complete) | 3.13 (1.49-6.67) | .003 |
| Predictor (final model) | Multivariable analysis OR (95% CI) | P |
| Omnibus Likelihood Ratio | <.001 | |
| DVT resolution (none/partial vs complete) | 3.15 (1.47-6.72) | .003 |
| Sex and group interaction | ||
| Male vs female in Non-LR | 0.59 (0.18-1.94) | .04 |
| Male vs female in LR | 2.50 (1.25-5.00) | |
| Non-LR vs LR among males | 1.17 (0.42-3.24) | |
| Non-LR vs LR among females | 4.92 (1.97-12.30) | |
| Predictor . | Univariable analysis OR (95% CI) . | P . |
|---|---|---|
| Group | ||
| Non-LR vs LRnon-neonates | 2.17 (1.12-4.20) | .01 |
| LRneonates vs LRnon-neonates | 0.67 (0.34-1.33) | |
| Treatment | ||
| None/prophylaxis vs thrombolysis | 0.20 (0.04-0.90) | .02 |
| Anticoagulants vs thrombolysis | 0.26 (0.10-0.66) | |
| Delay to start therapy, d | 1.03 (0.99-1.06) | .16 |
| Length of therapy, mo | 1.02 (0.98-1.05) | .37 |
| Age at the time of LE-DVT, y | 1.08 (1.03-1.12) | <.001 |
| Sex (male vs female) | 1.38 (0.80-2.38) | .24 |
| Number of affected venous segments | 1.36 (1.12-1.66) | .002 |
| DVT level (femoro-popliteal vs ilio-femoral) | 0.48 (0.11-2.15) | .34 |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 2.20 (0.95-5.09) | .07 |
| Recurrence (yes vs no) | 0.99 (0.21-4.78) | .98 |
| Thrombophilia | ||
| None vs major | 0.71 (0.29-1.72) | .78 |
| Minor vs major | 0.79 (0.25-2.43) | |
| DVT resolution (none/partial vs complete) | 3.13 (1.49-6.67) | .003 |
| Predictor (final model) | Multivariable analysis OR (95% CI) | P |
| Omnibus Likelihood Ratio | <.001 | |
| DVT resolution (none/partial vs complete) | 3.15 (1.47-6.72) | .003 |
| Sex and group interaction | ||
| Male vs female in Non-LR | 0.59 (0.18-1.94) | .04 |
| Male vs female in LR | 2.50 (1.25-5.00) | |
| Non-LR vs LR among males | 1.17 (0.42-3.24) | |
| Non-LR vs LR among females | 4.92 (1.97-12.30) | |
CI, confidence interval; OR, odds ratio.